Shaofei Wang Selected Research

Shaofei Wang Research Topics

Disease

15	Neoplasms (Cancer) 12/2019 - 01/2013
5	Inflammation (Inflammations) 01/2018 - 12/2005
3	Hepatocellular Carcinoma (Hepatoma) 06/2019 - 09/2014
3	Fibrosis (Cirrhosis) 01/2019 - 01/2017
3	Glioblastoma (Glioblastoma Multiforme) 08/2018 - 10/2017
3	Carcinogenesis 01/2018 - 01/2015
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2015 - 12/2014
3	Plague (Bubonic Plague) 03/2013 - 04/2008
2	Hepatitis 12/2018 - 01/2018
2	Hyperglycemia 03/2018 - 01/2017
2	Diabetic Nephropathies (Diabetic Nephropathy) 03/2018 - 01/2017
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2018 - 12/2005
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018 - 01/2013
2	Leukemia 10/2017 - 05/2016
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017 - 02/2015
2	Glioma (Gliomas) 08/2014 - 06/2013
2	Respiratory Syncytial Virus Infections 12/2005 - 05/2003
2	Virus Diseases (Viral Diseases) 12/2005 - 05/2003
1	Alcoholic Fatty Liver 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2019
1	Carcinoma (Carcinomatosis) 06/2019
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 03/2018
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Autoimmune Hepatitis 01/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2017
1	Rheumatoid Arthritis 01/2017
1	Proteinuria 01/2017
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 05/2016
1	Cicatrix (Scar) 04/2016
1	T-Cell Lymphoma (Lymphoma, T Cell) 02/2015
1	Myeloid Leukemia (Leukemia, Myelocytic) 02/2015
1	Melanoma (Melanoma, Malignant) 03/2014

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 12/2019 - 05/2003
4	Interleukin-22 (IL-22)IBA 01/2019 - 01/2017
3	ArginaseIBA 06/2019 - 03/2014
3	InflammasomesIBA 03/2018 - 01/2017
3	Asparaginase (Elspar)FDA Link 10/2017 - 02/2015
3	EnzymesIBA 01/2017 - 02/2015
3	Lipoproteins (Lipoprotein)IBA 03/2013 - 04/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2019 - 08/2018
2	Concanavalin AIBA 12/2018 - 01/2018
2	Streptozocin (Streptozotocin)FDA Link 03/2018 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 07/2007
2	Caspase 1 (ICE Protease)IBA 01/2018 - 01/2017
2	AsparagineIBA 10/2017 - 02/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 09/2014
2	Pharmaceutical PreparationsIBA 01/2017 - 09/2014
2	Arginine (L-Arginine)FDA Link 05/2016 - 03/2014
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 05/2016 - 09/2014
2	Tyrosine Kinase InhibitorsIBA 01/2015 - 12/2014
2	Dendrimers (Dendrons)IBA 09/2014 - 08/2014
2	Complement System Proteins (Complement)IBA 01/2013 - 05/2003
2	NF-kappa B (NF-kB)IBA 07/2007 - 12/2005
1	LigandsIBA 12/2019
1	Therapeutic UsesIBA 12/2019
1	HhAntag691IBA 01/2019
1	penetratinIBA 12/2018
1	Autophagy-Related Protein 5IBA 08/2018
1	NucleotidesIBA 03/2018
1	Glucose (Dextrose)FDA LinkGeneric 03/2018
1	taxifolinIBA 03/2018
1	BromidesIBA 01/2018
1	Immunoconjugates (Immunoconjugate)IBA 01/2018
1	CitrullineIBA 01/2018
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018
1	Cysteine (L-Cysteine)FDA Link 01/2018
1	monomethyl auristatin EIBA 01/2018
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2018
1	Interleukin-17 (Interleukin 17)IBA 01/2018
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2018
1	Transaminases (Aminotransferases)IBA 01/2018
1	CytokinesIBA 01/2018
1	Immune Checkpoint InhibitorsIBA 01/2018
1	Valine (L-Valine)FDA Link 01/2018
1	NLR ProteinsIBA 01/2018
1	Rituximab (Mabthera)FDA Link 01/2018
1	TOR Serine-Threonine KinasesIBA 01/2018
1	AntibodiesIBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	Protective AgentsIBA 01/2017
1	Caspase 3 (Caspase-3)IBA 01/2017
1	Biocompatible Materials (Biomaterials)IBA 04/2016
1	Essential Amino AcidsIBA 02/2015
1	Aspartic Acid (Aspartate)FDA Link 02/2015
1	AmmoniaIBA 02/2015
1	Imatinib Mesylate (Gleevec)FDA Link 01/2015
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2014
1	Poly(amidoamine)IBA 09/2014
1	Chloroquine (Aralen)FDA LinkGeneric 03/2014
1	InterferonsIBA 06/2013
1	LipopolysaccharidesIBA 03/2013
1	AcyltransferasesIBA 03/2013
1	Lipid AIBA 03/2013
1	lauric acid (dodecanoic acid)IBA 03/2013
1	HLA-DR Antigens (HLA-DR)IBA 01/2013

Therapy/Procedure

13	Therapeutics 01/2020 - 01/2013
2	Immunotherapy 08/2018 - 01/2018